AbCellera Biologics Inc.
ABCL$6.36▲ 11.19% 24h
AbCellera Biologics Inc.ABCL$6.36
+$4.13(+185.31%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$1.93B
P/E ratio
—
EPS (diluted)
$-0.49
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$75.13M
Net income
$-146.41M
Net margin
-194.9%
Gross margin
—
Dividends & financials
AbCellera Biologics Inc. (ABCL) reported revenue of $75.13M and net income of $-146.41M, or $-0.49 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.